In a pair of articles published in Lancet Gastroenterology & Hepatology, scientists lay out the case for why we should expand ...

Chronic hepatitis B treatment relies on nucleoside or nucleotide analogue drugs that suppress hepatitis B virus (HBV) ...

HHS Secretary Robert F. Kennedy Jr. and the CDC vaccine panel have been casting doubt on the hepatitis B shot and the practice of vaccinating newborns.

Let’s Break It Down,” emphasize the urgent need to remove barriers to prevention, testing, and treatment to reduce liver cancer and eliminate hepatitis by 2030.

In Nigeria, the prevalence among children under five stood at 0.3 per cent, slightly above the 2025 regional target.

TherVacB, a therapeutic vaccine for chronic hepatitis B, has entered its first clinical trial in patients. The first patient was enrolled in June 2025 and treated with the vaccine. In a previous trial ...

Hepatitis B is a liver infection that inflames the organ and impacts its ability to function. It can be either acute (short-term) or chronic (long-term), and is estimated to impact between 880,000 ...

Paper cited: Huang M et al. “Hepatitis B virus promotes liver cancer by modulating the immune response to environmental carcinogens” Nature Communications DOI: 10.1038/s41467-025-60894-z About ...

It was only after 1991, when the U.S. switched to a universal recommendation, that hepatitis B infections in children began to dramatically decline. Photo by kieferpix / stock.adobe.com .